Evidence map›Paper›PMID 32563607›Full record

ArticleVaccine2020

Global vaccine action plan lessons learned I: Recommendations for the next decade.

Noni MacDonald, Ezzeddine Mohsni, Yagob Al-Mazrou, Jon Kim Andrus, Narendra Arora, Susan Elden, Marie-Yvette Madrid, Rebecca Martin, Amani Mahmoud Mustafa, Helen Rees and 7 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Vaccine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Noni MacDonaldSAGE Decade of Vaccines Working Group; Professor of Paediatrics, Dalhousie University, IWK Health Centre, Canada. Chair of the SAGE Decade of Vaccines Working Group. Electronic address: Noni.MacDonald@Dal.Ca.
Ezzeddine MohsniSAGE Decade of Vaccines Working Group; Senior Technical Adviser in Global Health Development/Eastern Mediterranean Public Health Network.
Yagob Al-MazrouSAGE Decade of Vaccines Working Group; Secretary General - Health Services Council of the Kingdom of Saudi Arabia, Saudi Arabia.
Jon Kim AndrusSAGE Decade of Vaccines Working Group; Adjunct Professor and Director, Division of Vaccines and Immunization, Center for Global Health, University of Colorado, USA.
Narendra AroraSAGE Decade of Vaccines Working Group; Executive director, International Clinical Epidemiology Network, India.
Susan EldenSAGE Decade of Vaccines Working Group; Health Adviser, Department for International Development, London, UK.
Marie-Yvette MadridSAGE Decade of Vaccines Working Group; Independent Consultant, Geneva, Switzerland.
Rebecca MartinSAGE Decade of Vaccines Working Group; Director of the Center for Global Health, US CDC, USA.
Amani Mahmoud MustafaSAGE Decade of Vaccines Working Group; Project Manager, Sudan Public Health Training Initiative, Carter Center, Sudan.
Helen ReesSAGE Decade of Vaccines Working Group; Executive Director, Wits Reproductive Health and HIV Institute, Personal Professor, Ob/Gyn Codirector, African Leadership in Vaccinology Excellence, University of Witwatersrand, South Africa.
David SalisburySAGE Decade of Vaccines Working Group; Associate Fellow, Centre on Global Health Security, Chatham House, London, UK.
Qinjian ZhaoSAGE Decade of Vaccines Working Group; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, Xiamen University, Xiamen, Fujian, China.
Ian JonesJinja Publishing Ltd, Bishop's Stortford, UK.
Christoph A SteffenImmunization, Vaccines and Biologicals Department, World Health Organization, Geneva, Switzerland.
Joachim HombachImmunization, Vaccines and Biologicals Department, World Health Organization, Geneva, Switzerland.
Katherine L O'BrienImmunization, Vaccines and Biologicals Department, World Health Organization, Geneva, Switzerland.
Alejandro CraviotoFaculty of Medicine, Universidad Nacional Autónoma de México, Mexico City, Mexico; Chair, Strategic Advisory Group of Experts on Immunization (SAGE).

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Global Vaccine Action Plan 2011-2020 (GVAP) was developed to realize the ambitions of the Decade of Vaccines - that all individuals and communities enjoy lives free from vaccine-preventable diseases. It included a comprehensive monitoring and evaluation/accountability framework to assess progress towards global targets with recommendations for corrective actions. While many of the GVAP targets are very unlikely to be met by the end of 2020, substantial progress has nevertheless been made, establishing a strong foundation for a successor global immunization strategy, the Immunization Agenda 2030 (IA2030). The Strategic Advisory Group of Experts on immunization has made a series of recommendations to ensure that the lessons learned from GVAP inform the development and implementation of IA2030.

Indexed as

Immunization ProgramsVaccinesGlobal HealthHumansImmunizationVaccinationVaccinesGlobal healthGlobal Vaccine Action PlanGVAPIA2030ImmunizationImmunization Agenda 2030PolicyVaccination

Identifiers

PMID32563607
PMCPMC7342005

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.